These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9578045)

  • 1. Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine.
    Beran RG; Gibson RJ
    Epilepsia; 1998 Mar; 39(3):280-2. PubMed ID: 9578045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation.
    Ettinger AB; Weisbrot DM; Saracco J; Dhoon A; Kanner A; Devinsky O
    Epilepsia; 1998 Aug; 39(8):874-7. PubMed ID: 9701379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin.
    Steiner TJ; Dellaportas CI; Findley LJ; Gross M; Gibberd FB; Perkin GD; Park DM; Abbott R
    Epilepsia; 1999 May; 40(5):601-7. PubMed ID: 10386529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of lamotrigine efficacy on behavior disorders affecting patients with severe mental retardation].
    Kubagawa T; Furusho J; Isozaki Y
    No To Hattatsu; 2015 Jul; 47(4):289-92. PubMed ID: 26353451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine therapy of epilepsy in tuberous sclerosis.
    Franz DN; Tudor C; Leonard J; Egelhoff JC; Byars A; Valerius K; Sethuraman G
    Epilepsia; 2001 Jul; 42(7):935-40. PubMed ID: 11488895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).
    Donaldson JA; Glauser TA; Olberding LS
    Epilepsia; 1997 Jan; 38(1):68-73. PubMed ID: 9024186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of lamotrigine on epileptiform discharges in young patients with drug-resistant epilepsy.
    Eriksson AS; Knutsson E; Nergårdh A
    Epilepsia; 2001 Feb; 42(2):230-6. PubMed ID: 11240595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK; Kustra RP; Hammer AE
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine therapy in juvenile neuronal ceroid lipofuscinosis.
    Aberg L; Kirveskari E; Santavuori P
    Epilepsia; 1999 Jun; 40(6):796-9. PubMed ID: 10368082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration--effect and concentration--toxicity relations with lamotrigine: a prospective study.
    Kilpatrick ES; Forrest G; Brodie MJ
    Epilepsia; 1996 Jun; 37(6):534-8. PubMed ID: 8641229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
    Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine: a review of antiepileptic efficacy.
    Yuen AW
    Epilepsia; 1994; 35 Suppl 5():S33-6. PubMed ID: 8039468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concentration-effect relationship with lamotrigine (LTG).
    Gidal BE; Welty TE
    Epilepsia; 1997 Feb; 38(2):260. PubMed ID: 9048683
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of lamotrigine on epilepsy-induced cognitive impairment and hippocampal neuronal apoptosis in pentylenetetrazole-kindled animal model.
    Zhang B; Zhang JW; Wang WP; Dong RF; Tian S; Zhang C
    Synapse; 2017 Feb; 71(2):. PubMed ID: 27733018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of lamotrigine on refractory epilepsies in persons with severe motor and intellectual disabilities].
    Adachi M; Kawasaki Y
    No To Hattatsu; 2012 Nov; 44(6):445-9. PubMed ID: 23240524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
    Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
    Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine as add-on therapy in adult patients with refractory epilepsy.
    Yen DJ; Yiu CH; Kwan SY; Lin YY; Su MS
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 May; 59(5):303-7. PubMed ID: 9248123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.